Calidi Biotherapeutics, Inc.
CLDI
$1.36
$0.010.74%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.07M | 6.63M | 5.60M | 10.38M | 5.28M |
| Total Receivables | 266.00K | -- | -- | -- | 50.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 422.00K | 484.00K | 422.00K | 385.00K | 377.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 669.00K | 238.00K | 234.00K | 268.00K | 343.00K |
| Total Current Assets | 5.43M | 7.35M | 6.26M | 11.03M | 6.05M |
|
|
|||||
| Total Current Assets | 5.43M | 7.35M | 6.26M | 11.03M | 6.05M |
| Net Property, Plant & Equipment | 1.77M | 2.10M | 2.46M | 2.86M | 3.26M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 9.00K | 138.00K | 138.00K | 140.00K | 40.00K |
| Total Assets | 7.20M | 9.59M | 8.86M | 14.03M | 9.35M |
|
|
|||||
| Total Accounts Payable | 930.00K | 900.00K | 613.00K | 1.15M | 1.23M |
| Total Accrued Expenses | 1.13M | 1.43M | 1.81M | 2.17M | 1.93M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.18M | 1.50M | 1.52M | 1.87M | 2.19M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 3.24M | 3.84M | 3.94M | 5.19M | 5.35M |
|
|
|||||
| Total Current Liabilities | 3.24M | 3.84M | 3.94M | 5.19M | 5.35M |
| Long-Term Debt | 600.00K | 600.00K | 600.00K | 600.00K | 600.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 166.00K | 153.00K | 448.00K | 837.00K | 1.22M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 68.00K | 67.00K | 115.00K | 201.00K | 103.00K |
| Total Liabilities | 4.07M | 4.66M | 5.10M | 6.83M | 7.28M |
|
|
|||||
| Common Stock & APIC | 153.05M | 150.69M | 145.39M | 144.50M | 134.19M |
| Retained Earnings | -149.89M | -145.73M | -141.62M | -137.57M | -132.42M |
| Treasury Stock & Other | -26.00K | -22.00K | -13.00K | -13.00K | -13.00K |
| Total Common Equity | 3.13M | 4.94M | 3.76M | 6.92M | 1.76M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.13M | 4.94M | 3.76M | 6.92M | 1.76M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | 280.00K | 312.00K |
| Total Equity | 3.13M | 4.94M | 3.76M | 7.20M | 2.08M |
|
|
|||||